Leukemia Research
Volume 29, Issue 6 , Pages 661-664, June 2005

Analysis of HFE and TFR2 gene mutations in patients with acute leukemia

  • Dino Veneri

      Affiliations

    • Dipartimento di Medicina Sperimentale e Clinica, Divisione di Ematologia, Università di Verona, 37134 Verona, Italy
    • Corresponding Author InformationCorresponding author. Tel.: +39 045 8073610; fax: +39 045 8073612.
  • ,
  • Massimo Franchini

      Affiliations

    • Servizio di Immunoematologia e Trasfusionale, Azienda Ospedaliera di Verona, Verona, Italy
  • ,
  • Mauro Krampera

      Affiliations

    • Dipartimento di Medicina Sperimentale e Clinica, Divisione di Ematologia, Università di Verona, 37134 Verona, Italy
  • ,
  • Giovanna de Matteis

      Affiliations

    • Istituto di Analisi Chimico-Cliniche, Azienda Ospedaliera di Verona, Verona, Italy
  • ,
  • Pietro Solero

      Affiliations

    • Istituto di Analisi Chimico-Cliniche, Azienda Ospedaliera di Verona, Verona, Italy
  • ,
  • Giovanni Pizzolo

      Affiliations

    • Dipartimento di Medicina Sperimentale e Clinica, Divisione di Ematologia, Università di Verona, 37134 Verona, Italy

Received 6 December 2004; accepted 17 December 2004. published online 07 March 2011.

Abstract 

There are increasing evidences regarding the association between iron overload and extra-hepatic malignancies. We studied the prevalence of 12 hereditary hemochromatosis (HH) gene mutations (C282Y, V53M, V59M, H63D, H63H, S56C, Q127H, E168Q, E168X, W169X and Q283P in the HFE gene and Y250X in the TFR2 gene) and its correlation with the iron status in 82 adult patients with acute leukemia (AL); 48 patients (58.5%) were affected by acute myeloid leukemia (AML) and 34 patients (41.5%) by acute lymphoblastic leukemia (ALL); 27 patients (32.9%) had at least one HH gene mutation (6 heterozygous for C282Y, 6 homozygous for H63D, 13 heterozygous for H63D and 2 heterozygous for S56C). Mean serum ferritin levels at diagnosis were increased (822.5±811.4μg/L). However, there was no difference between patients positive or negative for the HH gene mutations. Similarly, we did not observe any statistically significant difference as far as iron status between AML and ALL patients. Our study does not support the evidence of an association between hemochromatosis gene mutations and iron overload in AL patients.

Keywords: Acute leukemia, Hereditary hemochromatosis, Iron overload

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0145-2126(05)00019-6

doi:10.1016/j.leukres.2005.01.001

Leukemia Research
Volume 29, Issue 6 , Pages 661-664, June 2005